# The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension

> **NCT06980922** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Intradialytic Hypotension
- End-Stage Renal Disease
- Hemodialysis

## Interventions

- **DRUG:** Guilu Erxian Jiao

## Key facts

- **NCT ID:** NCT06980922
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06980922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06980922, "The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06980922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*